Literature DB >> 12645193

Treatment of Toxoplasma brain abscess with clindamycin and sulfadiazine in an AIDS patient with concurrent atypical Pneumocystis carinii pneumonia.

Hung-Chin Tsai1, Susan Shin-Jung Lee, Hsi-Hsun Lin, Wei-Ru Lin, Yao-Shen Chen, Chun-Kai Huang, Yung-Ching Liu, Eng-Rin Chen.   

Abstract

Toxoplasmosis is the most common opportunistic infection of the central nervous system in patients with AIDS. The standard treatment for toxoplasmic encephalitis is pyrimethamine and sulfadiazine. There have been few reports of concurrent Toxoplasma brain abscess and cavitary Pneumocystis carinii pneumonia (PCP) in Taiwan. We report the case of a 26-year-old homosexual man with coexisting infection with Toxoplasma gondii and P. carinii who was successfully treated for brain abscess with clindamycin and sulfadiazine. The cavitary lung lesions, initially diagnosed as pulmonary tuberculosis, were proved to be PCP by lung biopsy. HIV infection and syphilis had been diagnosed 1 year before admission. He presented with general weakness, ataxia, nausea, blurred vision and fever for 2 weeks. Magnetic resonance imaging of the brain revealed multiple ring-enhanced lesions over the cerebrum and cerebellum. Chest roentgenography showed a 3-cm lesion with cavitation over the right upper lung field. Diagnostic computerized tomography-guided lung biopsy revealed P. carinii cysts. Clindamycin, sulfadiazine and trimethoprim (TMP)-sulfamethoxazole (20 mg/kg/day TMP) were given with good response. His CD4 count rose from 40 to 280/microL 4 months later. All antibiotics were discontinued after 4.5 months due to the development of a skin rash. He was well at follow-up 1 year later. This case suggests that the combination of clindamycin and sulfadiazine is an effective treatment for Toxoplasma brain abscess and highlights the importance of diagnostic lung biopsy for cavitary lung lesions, particularly in a region endemic for tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12645193

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  4 in total

1.  A novel benzodioxole-containing inhibitor of Toxoplasma gondii growth alters the parasite cell cycle.

Authors:  Edwin Kamau; Tracy Meehan; Mark D Lavine; Gustavo Arrizabalaga; Gabriela Mustata Wilson; Jon Boyle
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

2.  A focused small-molecule screen identifies 14 compounds with distinct effects on Toxoplasma gondii.

Authors:  Edwin T Kamau; Ananth R Srinivasan; Mark J Brown; Matthew G Fair; Erin J Caraher; Jon P Boyle
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 3.  Ockham's razor is not so sharp.

Authors:  Mark A Lewis; Kartik Agusala; Yuval Raizen
Journal:  Infect Dis Rep       Date:  2010-08-23

4.  Community-acquired intracranial suppurative infections: A 15-year report.

Authors:  Taner Yıldırmak; Habip Gedik; Funda Simşek; Arzu Kantürk
Journal:  Surg Neurol Int       Date:  2014-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.